Table 1. Inclusion criteria.

ART: antiretroviral treatment; CrCl: creatinine clearance; eGFR: estimated glomerular filtration rate; HIV: human immunodeficiency virus; TDF: tenofovir disoproxil fumarate

Study design	Cohort, case-control, cross-sectional studies (if the duration of TDF therapy was stated)
Article characteristics	Full articles, open-access dissertations/theses
Study participants	Age group: more than or equal to 18 years. Males, females, and transgenders. Patients diagnosed as HIV positive and on TDF-containing ART
Intervention	TDF-containing ART
Outcome	Kidney dysfunction indicated by any of the following outcome measurements: beta 2 microglobulinuria, fractional excretion of phosphate, fractional excretion of uric acid, N-acetyl-b-D-glucosaminidase, non-diabetic glycosuria, glycosuria, phosphaturia, CrCl, eGFR, serum creatinine, albumin creatinine ratio